Cross Country Healthcare buy Benchmark Co.
Start price
22.02.24
/
50%
€15.60
Target price
22.02.25
€19.41
Performance (%)
3.85%
End price
23.02.25
€16.20
Summary
This prediction ended on 23.02.25 with a price of €16.20. The BUY prediction by Benchmark_Co_ finished with a performance of 3.85%. Benchmark_Co_ has a follow-up prediction for Cross Country Healthcare where he still thinks Cross Country Healthcare is a Buy. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cross Country Healthcare | -3.571% | -3.571% | -16.923% |
iShares Core DAX® | 1.043% | -0.149% | 34.887% |
iShares Nasdaq 100 | 1.920% | 4.604% | 18.366% |
iShares Nikkei 225® | 4.840% | 8.328% | 10.637% |
iShares S&P 500 | 1.567% | 3.310% | 13.043% |
Comments by Benchmark_Co_ for this prediction
In the thread Cross Country Healthcare diskutieren
Cross Country Healthcare, Inc. (NASDAQ: CCRN) had its price target lowered by analysts at Benchmark Co. from $24.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for CCRN provided by MarketBeat
In the thread Trading Cross Country Healthcare
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Benchmark_Co_ for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€11.30
07.11.24
07.11.24
€16.64
07.11.25
07.11.25
-4.42%
12.08.25
12.08.25
Stopped prediction by Benchmark_Co_ for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€15.40
02.05.24
02.05.24
€17.74
02.05.25
02.05.25
-23.38%
03.05.25
03.05.25